Clinical Trial Update: Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial of cisplatin, bevacizumab, and gemcitabine followed by bevacizumab and paclitaxel in locally advanced nonmetastatic bladder cancer that can be rem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-07-12